Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results
The Pharma Data
JANUARY 9, 2021
CDMO Services assumes continued growth in Development Services (DVS), Drug Substance (DS) manufacturing, and Drug Product (DP) manufacturing and Packaging for both clinical- and commercial-stage projects on behalf of a growing list of pharmaceutical and biotechnology innovators and government/NGO customers. FOOTNOTES. (1)
40 
Let's personalize your content